Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Severe Acute Respiratory Syndrome (SARS) is a disease that first appeared in humans in November 2002. Infection initially brings flu-like symptoms including fever and fatigue, but it then attacks ...

“In general, transmission in Europe is driven by suboptimal vaccination coverage for measles in a number of EU/EEA countries.

As compared to controls, elevated nasal levels of ACE2 and TMPRSS2 were associated with a 3.6-fold increased risk of SARS-CoV ...

Otto and co-author Sean Edgerton, a PhD student focused on genomics and infectious diseases at the University of British ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the Omicron or Delta wave, particularly among fully vaccinated individuals.

The newest one to make people sick causes COVID-19, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first record of illness linked to SARS-CoV-2 was in China in ...

SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) are serious infectious respiratory diseases that are caused by members of a class of viruses known as coronaviruses ...

In mechanically ventilated patients with ARDS, the treatment effect of neuromuscular blockade on mortality likely varies with respiratory elastance.

VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat ...

Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute ...